September 11th 2012 – NYSCHP Mid-year Clinical Meeting: ETHICAL AND LEGAL ISSUES IN PHARMACY PRACTICE


Ethical and Legal Issues in Pharmacy Practice

Brochure

Midyear Materials

7:00am-8am         Experience With Switching to Outsourced Prefilled OR Syringes / PharMEDium Breakfast NO CE CREDIT

8:00am-9am         Contraceptive Issues


9:00am-10am       Afib

Pharmacist LO

1. Describe new and emerging therapeutic options for stroke prevention in AF.

2. Describe the primary changes related to stroke prevention in the 2011 focused updates to the ACCF/AHA/HRS guideline on the management of patients with AF.

3.Identify current and potential challenges and opportunities in stroke prevention in AF.10am-10:15am     Break

10:15-11:15am      Warfarin Management and the Ethics of the Status Quo

Pharmacist LO

1.  Describe the importance of taking anticoagulant therapy as directed and that diet plays a rolel

2.  Identify the importance of double checking when dispensing anticoagulant therapy

3.   List patient education that is key to good therapeutic outcomes for patient’s on anticoagulant therapy

Technician LO

1. Review key principals of the ethics of health care professions.

2.Consider how new knowledge and environmental changes alter expectations placed upon pharmacists.

3.Evaluate environmental changes relating to the provision and monitoring of oral anticoagulants, and identify potentially harmful aspects of the “status quo”.

4. Discuss how the concepts of continuous quality improvement align with principals of ethical pharmacy practice.

11:15-12:15pm      Biosimliars

Pharmacist LO

1.Define biosimilars and how they differ from traditional medications available in the United States.

2.Outline recent United States biosimilar legislation and its impact on drug approval.

3.Evaluate the safety and efficacy concerns in the utilization of biosimilar agents in practice.

4.Explain the role of the pharmacist in utilization decisions of biosimilars in practice.

Technician LO

1.Define biosimilars and how they differ from current monoclonal antibodies dispensed in practice.

2.List potential biosimilar agents that may impact dispensing trends in practice.

3.List adverse effects implicated in the use of biosimilar agents.

 

12:15-1:30pm       Lunch/Exhibits

1:30-2:30pm      Sedation

Pharmacist LO

1.Manage adult patients who need sedation and analgesia while receiving ventilator support according to current standards and guidelines

2.Use validated scales for sedation, pain, agitation, and delirium in the management of these critically ill patients

3.Assess recent clinical findings in sedation and analgesia management and incorporate them into the management of patients in the acute care, procedural, and surgical sedation settings

Sponsorship:

These activities are planned and conducted in part by ASHP Advantage and The France Foundation and supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc, Hospira, and GNYHA, Inc.

Contact:
Elizabeth Palillo
New York City Society of Health-Systems Pharmacists
212-420-2417
nycshp@gmail.com
 
When:
Tuesday September 11, 2012 from 7:00 AM to 2:30 PM
 
Where:
LaGuardia Marriott
East Elmhurst NY

To register, just follow the link below and fill in the appropriate information.

https://events.r20.constantcontact.com/register/eventReg?oeidk=a07e65cgx341316874e&oseq=l

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s